Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clive Ballard

Showing results (301-310 of 480) with videos related to

Pageof 48
Sort By:
The British Journal of Psychiatry : the Journal of Mental Science|October 9, 2025
Risk of stroke associated with risperidone in dementia with and without comorbid cardiovascular disease: population-based matched cohort studyJoshua Choma, Alys Griffiths, William Henley, et al.
Public Health|March 18, 2025
Early life factors and dementia risk: A study of adverse childhood experiences and later-life cognition and behaviourDinithi Mudalige, Dylan X Guan, Clive Ballard, et al.
The Lancet. Neurology|January 14, 2009
The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trialClive Ballard, Maria Luisa Hanney, Megan Theodoulou, et al.
BMC Health Services Research|May 12, 2026
Stakeholder perspectives on the potential benefits, risks, and implications of an interactive cognitive monitoring app for the identification and monitoring of cognitive decline in adults at risk of dementiaDaim Syukriyah, Claire Hulme, Chris Davis, et al.
Nature Reviews. Neurology|September 17, 2020
Drug repositioning and repurposing for Alzheimer diseaseClive Ballard, Dag Aarsland, Jeffrey Cummings, et al.
International Journal of Geriatric Psychiatry|November 18, 2003
Language impairment in dementia: impact on symptoms and care needs in residential homesDawn Potkins, Pat Myint, Carol Bannister, et al.
Trials|January 12, 2013
Feasibility study of an optimised person-centred intervention to improve mental health and reduce antipsychotics amongst people with dementia in care homes: study protocol for a randomised controlled trialRhiannon Whitaker, Clive Ballard, Jane Stafford, et al.
Brain Communications|May 15, 2025
Vascular risk factor associations with subjective cognitive decline and mild behavioural impairmentDylan X Guan, Aditya Aundhakar, Sarah Tomaszewski Farias, et al.
Neurochemistry International|December 3, 2021
Elevation of inactive cleaved annexin A1 in the neocortex is associated with amyloid, inflammatory and apoptotic markers in neurodegenerative dementiasXin Ying Chua, Joyce R Chong, Ai Ling Cheng, et al.
Nature. Mental Health|February 13, 2026
Autistic traits and suicidality in midlife and old age: investigating mediating effects of mental health and social connectednessEleanor Nuzum, Radvile Medeisyte, Aphrodite Eshetu, et al.
Pageof 48

Showing results (301-310 of 480) with videos related to

Sort By:
Pageof 48
The British Journal of Psychiatry : the Journal of Mental Science|October 9, 2025
Risk of stroke associated with risperidone in dementia with and without comorbid cardiovascular disease: population-based matched cohort studyJoshua Choma, Alys Griffiths, William Henley, et al.
Public Health|March 18, 2025
Early life factors and dementia risk: A study of adverse childhood experiences and later-life cognition and behaviourDinithi Mudalige, Dylan X Guan, Clive Ballard, et al.
The Lancet. Neurology|January 14, 2009
The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trialClive Ballard, Maria Luisa Hanney, Megan Theodoulou, et al.
BMC Health Services Research|May 12, 2026
Stakeholder perspectives on the potential benefits, risks, and implications of an interactive cognitive monitoring app for the identification and monitoring of cognitive decline in adults at risk of dementiaDaim Syukriyah, Claire Hulme, Chris Davis, et al.
Nature Reviews. Neurology|September 17, 2020
Drug repositioning and repurposing for Alzheimer diseaseClive Ballard, Dag Aarsland, Jeffrey Cummings, et al.
International Journal of Geriatric Psychiatry|November 18, 2003
Language impairment in dementia: impact on symptoms and care needs in residential homesDawn Potkins, Pat Myint, Carol Bannister, et al.
Trials|January 12, 2013
Feasibility study of an optimised person-centred intervention to improve mental health and reduce antipsychotics amongst people with dementia in care homes: study protocol for a randomised controlled trialRhiannon Whitaker, Clive Ballard, Jane Stafford, et al.
Brain Communications|May 15, 2025
Vascular risk factor associations with subjective cognitive decline and mild behavioural impairmentDylan X Guan, Aditya Aundhakar, Sarah Tomaszewski Farias, et al.
Neurochemistry International|December 3, 2021
Elevation of inactive cleaved annexin A1 in the neocortex is associated with amyloid, inflammatory and apoptotic markers in neurodegenerative dementiasXin Ying Chua, Joyce R Chong, Ai Ling Cheng, et al.
Nature. Mental Health|February 13, 2026
Autistic traits and suicidality in midlife and old age: investigating mediating effects of mental health and social connectednessEleanor Nuzum, Radvile Medeisyte, Aphrodite Eshetu, et al.
Pageof 48